Question

In: Finance

After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....

After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.45 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.6 million packages a year. Cash costs of production in the first year are expected to be $4.20 per package in real terms for the headache-only brand. Production costs are expected to be $4.75 in real terms for the headache and arthritis pill. All prices and costs are expected to rise at the general inflation rate of 3 percent.

Either product requires further investment. The headache-only pill could be produced using equipment costing $20 million. That equipment would last three years and have no resale value. The machinery required to produce the broader remedy would cost $29 million and last three years. The firm expects that equipment to have a $1,000,000 resale value (in real terms) at the end of Year 3. The firm uses straight-line depreciation and has a tax rate of 22 percent. The appropriate real discount rate is 7 percent.

a.

Calculate the NPV for headache pain reliever only.

b. Calculate the NPV for headache and arthritis pain reliever

Solutions

Expert Solution

Resale value and discount rate are given in real terms. so, project cash flows should also be in real terms.

NPV = Present value of cash inflows - initial investment

a. NPV for headache pain reliever only

Years 0 1 2 3 Total
Cost of equipment -$20,000,000 0 0 0 -$20,000,000
Sales quantity 0 3000000 3000000 3000000
Sales price/unit 0 $8.45 $8.45 $8.45
Production cost/unit 0 $4.20 $4.20 $4.20
Sales $0 $25,350,000 $25,350,000 $25,350,000 $76,050,000
Less: Production cost $0 $12,600,000 $12,600,000 $12,600,000 $37,800,000
Less: Depreciation $0 $6,666,667 $6,666,667 $6,666,667 $20,000,000
Pre-tax cash flow $0 $6,083,333 $6,083,333 $6,083,333 $18,250,000
Less: Taxes @22% $0 $1,338,333 $1,338,333 $1,338,333 $4,015,000
After-tax cash flow $0 $4,745,000 $4,745,000 $4,745,000 $14,235,000
Add back: Depreciation $0 $6,666,667 $6,666,667 $6,666,667 $20,000,000
Add: Sale of equipment $0 $0 $0 $0 $0
Less: Tax on equip. sale $0 $0 $0 $0 $0
Operating cash flow -$20,000,000 $11,411,667 $11,411,667 $11,411,667 $14,235,000
NPV $9,947,820

Formulas

b. NPV for headache and arthritis pain reliever

Tax on resale value of equipment = (sale value - book value)*tax rate

Book value = cost of equipment - total depreciation

depreciation = (cost of equipment - resale value)/life of equipment

Years 0 1 2 3 Total
Cost of equipment -$29,000,000 0 0 0 -$29,000,000
Sales quantity 0 4600000 4600000 4600000
Sales price/unit 0 $8.45 $8.45 $8.45
Production cost/unit 0 $4.75 $4.75 $4.75
Sales $0 $38,870,000 $38,870,000 $38,870,000 $116,610,000
Less: Production cost $0 $21,850,000 $21,850,000 $21,850,000 $65,550,000
Less: Depreciation $0 $9,333,333 $9,333,333 $9,333,333 $28,000,000
Pre-tax cash flow $0 $7,686,667 $7,686,667 $7,686,667 $23,060,000
Less: Taxes @22% $0 $1,691,067 $1,691,067 $1,691,067 $5,073,200
After-tax cash flow $0 $5,995,600 $5,995,600 $5,995,600 $17,986,800
Add back: Depreciation $0 $9,333,333 $9,333,333 $9,333,333 $28,000,000
Add: Sale of equipment $0 $0 $0 $1,000,000 $1,000,000
Less: Tax on equip. sale $0 $0 $0 $0 $0
Operating cash flow -$29,000,000 $15,328,933 $15,328,933 $16,328,933 $17,986,800
NPV $12,044,264

Formulas


Related Solutions

After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $9.10 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.2 million packages a year....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.85 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.6 million packages a year....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.60 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.4 million packages a year....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is to produce a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.85 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, while the headache and arthritis remedy would sell 4.6 million packages...
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is to produce a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.85 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, while the headache and arthritis remedy would sell 4.6 million packages...
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.50 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.7 million packages a year....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is to produce a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.75 per package in real terms. The headache-only medication is projected to sell 2 million packages a year, while the headache and arthritis remedy would sell 4 million packages...
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.50 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell 4.7 million packages a year....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market....
After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is to produce a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.90 per package in real terms. The headache-only medication is projected to sell 2 million packages a year, while the headache and arthritis remedy would sell 3.5 million packages...
1. Project Analysis and Inflation After extensive medical and marketing research, Pill, Inc., believes it can...
1. Project Analysis and Inflation After extensive medical and marketing research, Pill, Inc., believes it can penetrate the pain reliever market. It is considering two alternative products. The first is a medication for headache pain. The second is a pill for headache and arthritis pain. Both products would be introduced at a price of $8.35 per package in real terms. The headache-only medication is projected to sell 3 million packages a year, whereas the headache and arthritis remedy would sell...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT